Caricamento...
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDA) is a lethal malignancy with an overall 5-year survival rate of 10%. Disease lethality is due to late diagnosis, early metastasis and resistance to therapy, including immunotherapy. PDA creates a robust fibroinflammatory tumor microenvironment that contributes t...
Salvato in:
| Pubblicato in: | Front Immunol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7876239/ https://ncbi.nlm.nih.gov/pubmed/33584701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.613815 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|